RxDoctor Payments Data

Lacy Graham, APRN

Family · Duarte, CANPI 1225439391

Payments from drug & device makers

$1,534in general payments, 2019–2025

Across 68 payments — averaging $22.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$427
  • AbbVie$227
  • Astellas Pharma US Inc$182
  • Genentech USA, Inc.$141
  • Bristol Myers Squibb$136
  • Amgen$78
  • plus $342 from 11 others

What the payments were for

  • Food & beverage$1,33687%
  • Education$19813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,534 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.

See all family providers in California

Medicare billing

Part B allowed, 2024
$6,457
Medicare patients
41
Services billed
87

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Duarte

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →